Literature DB >> 20667665

Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC): molecular mechanisms and novel paradigms.

C Brechot1, D Kremsdorf, P Soussan, P Pineau, A Dejean, P Paterlini-Brechot, P Tiollais.   

Abstract

Chronic hepatitis B (HBV) infection is a major risk factor for hepatocellular carcinoma (HCC). Most HCCs complicate the evolution of an active or inactive cirrhosis. However, some tumors occur on livers with minimal histological changes; the prevalence of such cases varies from one geographical region to the other, being much higher in the Southern half of Africa (around 40% of HCCs) than in Asia, America and Europe, where at least 90% of HCCs are associated in the cirrhosis. This heterogeneity is probably a reflection of different environmental and genetic factors. This review will summarise the current knowledge on the mechanisms involved in HBV-related liver carcinogenesis. It will show in particular how viruses can be viewed as tools to discover and dissect new cellular pathways involved in cancer development and emphasize the potential synergistic effects between HBV and hepatitis C virus (HCV), as well as between viral infections and other environmental factors, such as alcohol. Copyright 2010. Published by Elsevier SAS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20667665     DOI: 10.1016/j.patbio.2010.05.001

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  28 in total

1.  Significance of Glypican-3 in Early Detection of Hepatocellular Carcinoma in Cirrhotic Patients.

Authors:  Ahmed M Tahon; Magdy Z El-Ghanam; Samy Zaky; Tarek Mostafa Emran; Ali M Bersy; Fathiya El-Raey; Elsayed A Z; Amr M El Kharsawy; Dina Johar
Journal:  J Gastrointest Cancer       Date:  2019-09

2.  HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress.

Authors:  Vonetta M Williams; Maria Filippova; Ubaldo Soto; Penelope J Duerksen-Hughes
Journal:  Future Virol       Date:  2011-01-01       Impact factor: 1.831

3.  GST polymorphisms are associated with hepatocellular carcinoma risk in Chinese population.

Authors:  Lei Yu; Chun-Yu Wang; Bo Xi; Lei Sun; Ruo-Qi Wang; Yin-Kun Yan; Li-Ying Zhu
Journal:  World J Gastroenterol       Date:  2011-07-21       Impact factor: 5.742

Review 4.  Potential mechanisms of hepatitis B virus induced liver injury.

Authors:  Mohd Suhail; Hany Abdel-Hafiz; Ashraf Ali; Kaneez Fatima; Ghazi A Damanhouri; Esam Azhar; Adeel Ga Chaudhary; Ishtiaq Qadri
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

5.  Hepatitis B Virus Infection can Cause Hepatocellular Carcinoma in Less Advanced Liver Cirrhosis: A Comparative Study of 142 Patients from North India.

Authors:  Anil Arora; Praveen Sharma; Pankaj Tyagi; Vikas Singla; Veronica Arora; Naresh Bansal; Jay Toshniwal; Ashish Kumar
Journal:  J Clin Exp Hepatol       Date:  2013-09-20

6.  Sustained inhibition of hepatitis B virus replication in vivo using RNAi-activating lentiviruses.

Authors:  D Ivacik; A Ely; N Ferry; P Arbuthnot
Journal:  Gene Ther       Date:  2014-10-23       Impact factor: 5.250

Review 7.  Molecular mechanisms underlying occult hepatitis B virus infection.

Authors:  Jasmine Samal; Manish Kandpal; Perumal Vivekanandan
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

8.  HapMap-based study of CIP2A gene polymorphisms and HCC susceptibility.

Authors:  Yuchun Li; Kaijuan Wang; Liping Dai; Peng Wang; Chunhua Song; Jianxiang Shi; Pengfei Ren; Hua Ye; Jianying Zhang
Journal:  Oncol Lett       Date:  2012-05-23       Impact factor: 2.967

Review 9.  Transposon mouse models to elucidate the genetic mechanisms of hepatitis B viral induced hepatocellular carcinoma.

Authors:  Amy P Chiu; Barbara R Tschida; Lilian H Lo; Branden S Moriarity; Dewi K Rowlands; David A Largaespada; Vincent W Keng
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

10.  Occult hepatitis B virus infection among injecting drug users in the Central-West Region of Brazil.

Authors:  Márcia Alves Dias de Matos; Renata Carneiro Ferreira; Fabiana Perez Rodrigues; Tamíris Augusto Marinho; Carmen Luci Rodrigues Lopes; Antônia Carlos Magalhães Novais; Ana Rita Coimbra Motta-Castro; Sheila Araújo Teles; Francisco José Dutra Souto; Regina Maria Bringel Martins
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-05       Impact factor: 2.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.